Taiwan FDA registration e0678b9ae3882764f36943e164da60f1

"Bard" Arestar absorbs hemostatic particles

TW: “巴德”亞瑞絲達可吸收止血顆粒

Taiwan·Risk Class 3·DAVOL, INC., SUBSIDIARY OF C.R. BARD,INC.;;DAVOL INC.·Registered Feb 05, 2018 – Feb 05, 2028Active

Registration details

Analysis ID: e0678b9ae3882764f36943e164da60f1
Customs Code: DHA05603069608

Company information

Manufacturer: DAVOL, INC., SUBSIDIARY OF C.R. BARD,INC.;;DAVOL INC.
Manufacturer Country: United States
Authorized Representative: BARD PACIFIC HEALTH CARE CO., LTD.

Product details

Intended Use: This product is an auxiliary hemostatic device, suitable for surgical procedures (except neurological and ophthalmic surgery), when compression, ligation and other routine operations (including suturing and electrocautery, etc.) are ineffective or impossible to control capillary vessels, veins and arteriole bleeding.
Product Type (Level 1): I General, Plastic Surgery and Dermatology
Product Type (Level 2): I.4490 Absorbable hemostats and dressings
Import Information: Contract manufacturing;; input

Dates and status

Registration Date: Feb 05, 2018
Expiry Date: Feb 05, 2028

About this record

Access comprehensive regulatory information for "Bard" Arestar absorbs hemostatic particles in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number e0678b9ae3882764f36943e164da60f1 and manufactured by DAVOL, INC., SUBSIDIARY OF C.R. BARD,INC.;;DAVOL INC.. The authorized representative in Taiwan is BARD PACIFIC HEALTH CARE CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.